Literature DB >> 18467673

A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.

Richard A Greenberg1, Gwen Kerby, Genie E Roosevelt.   

Abstract

The aim of this study was to determine if 2 doses of oral dexamethasone are as effective as a 5-day course of oral prednisone in preventing relapse for pediatric asthma exacerbations. Patients presenting to the emergency department with an asthma exacerbation were randomized to receive 0.6 mg/kg of dexamethasone or 2 mg/kg of prednisone in a prospective, double-blind study. The primary outcome was relapse within 10 days, and the secondary outcome was vomiting in the emergency department. Eighty-nine patients completed the study: 38 in the prednisone group and 51 in the dexamethasone group. In all, 3 patients in the prednisone group (8%) and 8 patients in the dexamethasone group (16%) required an unscheduled follow-up visit (P = .27). In all, 7 patients in the prednisone group (18%) and 5 patients in the dexamethasone group (10%) had vomiting ( P = .24). No difference was found in the relapse rate or incidence of vomiting between patients given prednisone and dexamethasone for pediatric asthma exacerbations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467673     DOI: 10.1177/0009922808316988

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  16 in total

Review 1.  Asthma outcomes: exacerbations.

Authors:  Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone.

Authors:  Jillian M Cotter; Amy Tyler; Jennifer Reese; Sonja Ziniel; Monica J Federico; William C Anderson Iii; Oren Kupfer; Stanley J Szefler; Gwendolyn Kerby; Heather E Hoch
Journal:  J Asthma       Date:  2019-06-12       Impact factor: 2.515

3.  Asthma Review for Pharmacists Providing Asthma Education.

Authors:  Stacie J Lampkin; Cheryl A Maslouski; William A Maish; Barnabas M John
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

4.  Genetic risk factors for decreased bone mineral accretion in children with asthma receiving multiple oral corticosteroid bursts.

Authors:  Heung-Woo Park; Bing Ge; Szeman Tse; Elin Grundberg; Tomi Pastinen; H William Kelly; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2015-05-27       Impact factor: 10.793

Review 5.  Single-dose dexamethasone for mild-to-moderate asthma exacerbations: effective, easy, and acceptable.

Authors:  Keith P Cross; Ronald I Paul; Ran D Goldman
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

6.  Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients.

Authors:  Allan E Shefrin; Ran D Goldman
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

Review 7.  Dexamethasone for acute asthma exacerbations in children: a meta-analysis.

Authors:  Grant E Keeney; Matthew P Gray; Andrea K Morrison; Michael N Levas; Elizabeth A Kessler; Garick D Hill; Marc H Gorelick; Jeffrey L Jackson
Journal:  Pediatrics       Date:  2014-02-10       Impact factor: 7.124

8.  Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children.

Authors:  Dalia A Elkharwili; Osama M Ibrahim; Gamal A Elazab; Shaymaa M Elrifaey
Journal:  Eur J Hosp Pharm       Date:  2018-11-10

9.  Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial.

Authors:  John Cronin; Una Kennedy; Siobhan McCoy; Sinéad Nic An Fhailí; Gloria Crispino-O'Connell; John Hayden; Abel Wakai; Sean Walsh; Ronan O'Sullivan
Journal:  Trials       Date:  2012-08-21       Impact factor: 2.279

10.  ISU201 enhances the resolution of airway inflammation in a mouse model of an acute exacerbation of asthma.

Authors:  Yuka Hiroshima; Linda Garthwaite; Kenneth Hsu; Hyouna Yoo; Sang-Ho Park; Carolyn L Geczy; Rakesh K Kumar; Cristan Herbert
Journal:  Mediators Inflamm       Date:  2015-02-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.